发明授权
- 专利标题： Hepatitis C virus inhibitors
- 专利标题（中）： 丙型肝炎病毒抑制剂
-
申请号： US12879026申请日： 2010-09-10
-
公开(公告)号： US08703938B2公开(公告)日： 2014-04-22
- 发明人: Yat Sun Or , Ce Wang , Lu Ying , Xiaowen Peng , Yao-Ling Qiu
- 申请人： Yat Sun Or , Ce Wang , Lu Ying , Xiaowen Peng , Yao-Ling Qiu
- 申请人地址： US MA Watertown
- 专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Watertown
- 代理机构： Elmore Patent Law Group, P.C.
- 代理商 Roy P. Issac, Esq.; Carolyn S. Elmore, Esq.
- 主分类号： C07D403/12
- IPC分类号： C07D403/12 ; C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D417/12
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention relates to novel antiviral compounds represented herein above, pharmaceutical compositions comprising such compounds, and methods for the treatment or prophylaxis of viral (particularly HCV) infection in a subject in need of such therapy with the compounds.
公开/授权文献
- US20110064696A1 HEPATITIS C VIRUS INHIBITORS 公开/授权日：2011-03-17
信息查询
